Overview

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

Status:
Completed
Trial end date:
2019-01-15
Target enrollment:
Participant gender:
Summary
This study will evaluate bioequivalence of two formulations of Ferric Carboxymaltose as measured by serum total iron, in adult patients with iron deficiency anemia.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Ferric Compounds